Assessing the reproducibility of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer
Open Access
- 27 July 2012
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 69 (6), 1721-1734
- https://doi.org/10.1002/mrm.24422
Abstract
Quantitative dynamic contrast enhanced magnetic resonance imaging estimates parameters related to tissue vascularity and volume fractions; additionally, semiquantitative parameters such as the initial area under the curve can be utilized to describe tissue behavior. The aim of this study was to establish the reproducibility of quantitative and semiquantitative analysis of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer. For each animal, a T1‐weighted, gradient‐echo sequence was used to acquire two sets of dynamic contrast enhanced magnetic resonance imaging data separated by 5 h. Data were acquired at both a 0.05 mm3 (1282, n = 12) and a 0.2 mm3 (642, n = 12) resolution, and analysis was performed using both the Tofts–Kety (to estimate K trans and v e) and extended Tofts–Kety (K trans, v e, and v p) models. Reproducibility analysis was performed for both the center slice and the total tumor volume for all parameters. For the total volume analysis, the repeatability index for K trans is 0.073 min−1 in the standard model analysis and 0.075 min−1 in the extended model analysis at the 1282 acquisition. For the 642 acquisition, the values are 0.089 and 0.063 min−1 for the standard and extended models, respectively. The repeatability index for initial area under the curve was 0.0039 and 0.0042 mM min for the 1282 and 642 acquisitions, respectively. Magn Reson Med, 2013.Funding Information
- National Cancer Institute (R01CA138599, R25CA092043, P30 CA68485)
This publication has 35 references indexed in Scilit:
- Statistical comparison of dynamic contrast‐enhanced MRI pharmacokinetic models in human breast cancerMagnetic Resonance in Medicine, 2011
- A quantitative comparison of the influence of individual versus population-derived vascular input functions on dynamic contrast enhanced-MRI in small animalsMagnetic Resonance in Medicine, 2011
- DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6British Journal of Cancer, 2011
- PET imaging of early response to the tyrosine kinase inhibitor ZD4190European Journal of Nuclear Medicine and Molecular Imaging, 2011
- Evaluation of KRAS Mutations, Angiogenic Biomarkers, and DCE-MRI in Patients with Advanced Non–Small-Cell Lung Cancer Receiving SorafenibClinical Cancer Research, 2011
- Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effectsNMR in Biomedicine, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Early Changes in Functional Dynamic Magnetic Resonance Imaging Predict for Pathologic Response to Neoadjuvant Chemotherapy in Primary Breast CancerClinical Cancer Research, 2008
- A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imagingBritish Journal of Cancer, 2006
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974